Dexcom and Kore have formed an ongoing partnership to deliver a remote-patient-monitoring solution to assist care providers during the COVID-19 pandemic.
In order to successfully monitor the glucose levels of patients who are being treated for COVID-19, healthcare professionals (HCPs) must equip themselves with fresh personal protective equipment (PPE) for each visit.
Patients on insulin need several glucose checks per day, up to one per hour – meaning multiple PPEs are discarded each day, for each patient.
Dexcom’s solution allows for continuous glucose monitoring by measuring glucose levels automatically every five minutes and transmitting the data to a handheld mobile device, which can be accessed from a safe distance. HCPs can then safely and accurately monitor blood glucose levels remotely – only using one set of PPE daily in order to change out the device, or other times immediate intervention is necessary.
Dexcom approached Kore Health to help launch this solution with record speed in order to maximize protection for areas that need it most.
In a release, Bryan Lubel, EVP of IoT Managed Services, commented, “Kore Health was able to procure fully certified and ISO-compliant devices, complete engineering testing and approval, identify connectivity solutions and deploy the first wave of equipped devices in just over a week – ensuring rapid speed-to-market for this critical solution.”